118 related articles for article (PubMed ID: 25316005)
1. Re-irradiation in head and neck cancers: an Indian tertiary cancer centre experience.
Mallick S; Gandhi AK; Joshi NP; Pandit S; Bhasker S; Sharma A; Thakar A; Mohanti BK
J Laryngol Otol; 2014 Nov; 128(11):996-1002. PubMed ID: 25316005
[TBL] [Abstract][Full Text] [Related]
2. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
[TBL] [Abstract][Full Text] [Related]
3. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
4. Re-irradiation of head and neck cancer-impact of total dose on outcome.
Janssen S; Baumgartner M; Bremer M; Warszawski A; Stieve M; Eckardt A; Karstens JH; Meyer A
Anticancer Res; 2010 Sep; 30(9):3781-6. PubMed ID: 20944169
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
[TBL] [Abstract][Full Text] [Related]
7. Conformal re-irradiation of recurrent and new primary head-and-neck cancer.
Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224
[TBL] [Abstract][Full Text] [Related]
8. Salvage re-irradiation for recurrent head and neck cancer.
Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience.
Al-Wassia R; Vakilian S; Holly C; Sultanem K; Shenouda G
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):31. PubMed ID: 26330008
[TBL] [Abstract][Full Text] [Related]
10. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
11. Re-irradiation for recurrent and second primary cancers of the head and neck.
Velez MA; Veruttipong D; Wang PC; Chin R; Beron P; Abemayor E; St John M; Chen AM
Oral Oncol; 2017 Apr; 67():46-51. PubMed ID: 28351580
[TBL] [Abstract][Full Text] [Related]
12. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
15. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.
Rwigema JC; Heron DE; Ferris RL; Gibson M; Quinn A; Yang Y; Ozhasoglu C; Burton S
Am J Clin Oncol; 2010 Jun; 33(3):286-93. PubMed ID: 19875950
[TBL] [Abstract][Full Text] [Related]
16. Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients.
Ohguri T; Imada H; Yahara K; Moon SD; Yamaguchi S; Yatera K; Mukae H; Hanagiri T; Tanaka F; Korogi Y
Lung Cancer; 2012 Jul; 77(1):140-5. PubMed ID: 22445656
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife.
Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Kotsuma T; Yoshida K; Yoshioka Y
Radiat Oncol; 2015 Oct; 10():210. PubMed ID: 26471020
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity.
Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581
[TBL] [Abstract][Full Text] [Related]
19. A review on re-irradiation for recurrent and second primary head and neck cancer.
Kasperts N; Slotman B; Leemans CR; Langendijk JA
Oral Oncol; 2005 Mar; 41(3):225-43. PubMed ID: 15743686
[TBL] [Abstract][Full Text] [Related]
20. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach.
Cacicedo J; Navarro A; Alongi F; Gómez de Iturriaga A; Del Hoyo O; Boveda E; Casquero F; Perez JF; Bilbao P
Cancer Treat Rev; 2014 Feb; 40(1):178-89. PubMed ID: 23993769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
